Cardiology Group pays $2 million to settle bogus claims

Published Date: 02 Mar 2023

Florida Cardiology PA and 10 cardiologists have filed a bogus lawsuit and must pay $2 million to settle the lawsuit outside the United States and will still “deny” wrongdoing.

Read Full News

Latest News

VT3989 continues to show promising early results in patients with advanced mesothelioma

The first-in-class YAP-TEAD inhibitor VT3989 continued to be well tolerated and demonstrated notable initial antitumor activity, particularly in patients with refractory mesothelioma, according to results from a trial led ...

Supercharging immune cells to fight drug resistant bowel cancer

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to new treatments in the future.

'Craters' on surface of melanoma cells mark tumor-killing hotspots, study reveals

New research published in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, becoming major sites for tumor killing. These craters could serve as good markers for immunotherapy ...

Modified virus boosts cancer vaccine effectiveness in mouse experiments

Could a future vaccine against cancer be made better by an immune-boosting virus? Very likely, say Canadian scientists, who've proven its effectiveness in experiments on mice.

Biomarker analysis reveals clues to long-term survival in glioblastoma patients treated with SurVaxM

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly diagnosed glioblastoma patients survive longer than others after receiving standard treatment in conjunction ...

How bacteria in tumors drive treatment resistance in cancer

Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer. The ...

Todays Updates

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...

Obesity-related cancer rising among both younger and older adults worldwide, study finds

A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.

Todays Updates

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...

Obesity-related cancer rising among both younger and older adults worldwide, study finds

A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.

Latest News

The first-in-class YAP-TEAD inhibitor VT3989 continued to be well tolerated and demonstrated notable initial antitumor activity, particularly in patients with refractory mesothelioma, according to results from a trial led ...

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to new treatments in the future.

New research published in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, becoming major sites for tumor killing. These craters could serve as good markers for immunotherapy ...

Could a future vaccine against cancer be made better by an immune-boosting virus? Very likely, say Canadian scientists, who've proven its effectiveness in experiments on mice.

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly diagnosed glioblastoma patients survive longer than others after receiving standard treatment in conjunction ...

Researchers from The University of Texas MD Anderson Cancer Center have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance in patients with oral and colorectal cancer. The ...

News All Time

Skin symptoms may forewarn mental health risks

Scientists have discovered that mental health patients who have skin conditions may be more at risk of worse outcomes, including suicidality and depression. This work, which may aid in identifying at-risk patients and personalizing ...

Blood cancer: Scientists reprogram cancer cell death to trigger immune system

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm successfully stimulated an effective ...

FDA approves Zoryve for atopic dermatitis in young children

The U.S. Food and Drug Administration has approved the supplemental new drug application for Zoryve (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in children 2 to 5 years of age.

Study reveals a link between World Trade Center toxic exposures and lung cancer

The health risks from toxic exposures at Ground Zero of the 9/11 World Trade Center attacks are well documented, and diseases caused by those exposures continue to plague WTC responders as we approach 25 years since 9/11. ...

Certain dietary fatty acids can supercharge cancer-fighting immune cells

A research team at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has discovered that certain dietary fatty acids can supercharge the human immune system's ability to fight cancer. The team found that ...

Seasonal allergies may increase suicide risk: New research

Seasonal allergies—triggered by pollen—appear to make deaths by suicide more likely. Our findings, published in the Journal of Health Economics, show that minor physical health conditions like mild seasonal allergies, ...

Cancer researchers highlight role of nanomedicine in next-generation immunotherapies

Scientists at Virginia Tech's Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer immunotherapy with back-to-back review articles published in Nature Cancer and Trends ...

Engineered CAR-NK cells could evade immune rejection and target cancer more effectively

One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells. Similar to CAR-T cells, these cells can be programmed to attack cancer cells.

Breastfeeding for at least six months strengthens immunity in babies, study suggests

Breastfeeding until at least six months helps babies to fight off infections and reduces chronic inflammation, according to a new study. And better understanding the way specific nutrients in breast milk impact the immune ...

Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma

A multi-institutional study from the Accelerating GBM Therapies Through Serial Biopsies TeamLab, led by investigators from the Mass General Brigham Cancer Institute, found that serially testing tumor samples can help detect ...

Novel immunotherapy combination destroys colorectal liver metastases

Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to the liver. Despite progress ...

From trips to treatments: How psychedelics could revolutionize anti-inflammatory medicine

Once synonymous with hippies and hallucinatory experiences, psychedelic drugs are now being explored for their medical potential. The stigma of that era resulted in research being suppressed by drug laws, yet with mental ...

What a respiratory system expert wants you to know about asthma

We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to inflammatory responses, can be caused throughout our lifetime by a variety of things. It can be treated ...

Could reducing inflammation help combat fatigue in people with early-stage breast cancer?

New research reveals that inflammatory responses may play a role in different types of fatigue experienced by many people with cancer. The findings are published in Cancer.

Severe obesity causes lungs to age prematurely, study suggests

A research team has determined that severe obesity causes the lungs to age faster. The team was led by Prof. Dr. Veronika Lukacs-Kornek from the "ImmunoSensation2" Cluster of Excellence at the University of Bonn and the Institute ...

Mechanisms of rare skin disease point to new treatments

People with Sweet's syndrome often wake up with a fever, body aches, and blisters on their neck, limbs and face. Also known as acute febrile neutrophilic dermatosis, it is an inflammatory skin disease marked by severe symptoms ...

Recommended News For You

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

Improved end-of-life conversations for cancer patients are identified by a new study.

ALK-positive lung cancer trial results show unprecedented progression-free survival.

the contribution of cortactin to the development of cancer.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Recommended Articles For You

A Visual Journey Through Penile Cancer: Examining the Impact of Photos 

What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder 

Understanding Axitinib: What You Need To Know For Your Treatment Plan 

The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel Agent Effective for Cancer Wasting Disorder

2.

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

3.

A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.

4.

Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy

5.

Scientists call into question safety of potential new anticancer treatment

1.

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know

2.

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits

3.

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making

4.

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access

5.

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- The Incidence of Cancer in Men

2.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot